Canadian Cancer Screening Conference
Maximizing benefits, minimizing harms
Montreal, Quebec
March 21-22 2012
The Canadian Partnership Against Cancer is sponsoring a Canadian Cancer Screening Conference
to convene screening stakeholders from across the country to hear about the latest evidence
and approaches to cancer screening for both well-established cancer-screening sites and for
controversial and emerging areas. Issues such as quality improvement in screening and
approaches to implementing screening strategies in the future will also be topics of discussion.
The conference will:
1. Update participants on key aspects of the established cancer screening sites – breast,
cervix and colorectum including screening recommendations, new tests and
international perspectives
2. Provide expert presentations on emerging issues related to high risk populations,
potential for new tests and quality of screening
3. Discuss opportunities for monitoring and improving quality with indicators and target
setting
4. Examine the future directions of screening programs and services in Canada
Canadian Cancer Screening Conference: Maximizing Benefits, Minimizing Harms
DRAFT Agenda
Montreal, Quebec
March 21-22, 2012
DAY 1
A hot breakfast will be served (7:30-8:30 am)
8:30 – 8:50
Welcome and opening remarks
The Canadian Partnership Against Cancer:
Priorities for 2012-2017
Jessica Hill
Chief Executive Officer, Canadian Partnership
Against Cancer
8:50 – 9:00
Early detection in the cancer control spectrum
Heather Bryant
Vice President, Cancer Control, Canadian
Partnership Against Cancer
Agenda overview
Verna Mai
Chair, Screening Advisory Group, Canadian
Partnership Against Cancer
9:00 -9:10
BREAST CANCER SCREENING
A series of presentations providing an overview on breast cancer screening guidelines. Presentations will also
explore current practices, future potential impacts and the risks and benefits of breast cancer screening.
International perspectives and experiences will also be shared.
9:10 – 9:30
Canada – Canadian Task Force on Preventive
Health Care: 2010 Guidelines for Breast Cancer
Screening in Average Risk Women
Marcello Tonelli
Chair, Canadian Task Force on Preventative
Health
Associate Professor, University of Alberta,
Canada (Alberta)
9:30 – 9:50
U.S.A. – Breast Cancer Screening Guidelines in
Context: The USPSTF recommendations
revisited
Stephen Taplin
Acting Branch Chief, Process of Care
Research Branch, Division of Cancer Control
and Population Sciences, Behavioral
Research Program, National Cancer Institute,
U.S.A.
9:50 – 10:10
United Kingdom – A U.K. perspective
Julietta Patnick
Director, NHS Cancer Screening
Programmes, National Health Services, U.K.
Visiting Professor, Cancer Screening,
University of Oxford
10:10 – 10:30
Panel Q&A for all three presentations
All presenters
Moderator: Verna Mai
Canadian Partnership Against Cancer
MORNING BREAK (10:30-10:55 am)
2
Cervical AND COLORECTAL CANCER SCREENING
A series of presentations exploring established cancer-screening sites for cervical and colorectal cancer.
Presentations will look at new screening tests, their role in population screening and the risks and benefits of
screening for cervical and colorectal cancer. International perspectives and experiences will also be shared.
10:55 –11:15
New developments, evidence, tests and future
scenarios in cervical cancer screening
Eduardo Franco
James McGill Professor and Director, Division
of Cancer Epidemiology, and Interim Chair,
Department of Oncology, McGill University,
Canada (Quebec)
11:15 – 11:30
Young women and cervical cancer screening
Julietta Patnick
Director, NHS Cancer Screening
Programmes, National Health Services, U.K.
11:30 – 11:45
Getting to where we want to go with cervical
cancer screening
Meg McLachlin
Chair, Pan-Canadian Cervical Cancer
Screening Initiative
Medical Director, Anatomic Pathology,
London Health Sciences Centre, Canada
(Ontario)
11:45 – 12:10
The National Bowel Cancer Screening Program
in Australia
Graeme Young
Professor of Global GI Health, Flinders
University, Australia
12:10 – 12:25
Flexible Sigmoidoscopy: The evidence and role
as a screening option
Linda Rabeneck
Vice President, Prevention & Cancer Control,
Cancer Care Ontario, Canada (Ontario)
Professor of Medicine and Health Policy,
Management and Evaluation, Dalla Lana
School of Public Health, University of
Toronto, Canada (Ontario)
12:25 – 12:45 Panel Q&A for all cervical and colorectal cancer
screening presentations
All presenters
Moderator: Verna Mai
Canadian Partnership Against Cancer
LUNCH (12:45 – 13:45 pm)
3
GROUP DISCUSSION
Three small group sessions (breast, cervical and colorectal cancer screening) will be held concurrently. Each group
will explore key issues for screening high-risk populations, the need for specialized services, quality issues with
cancer screening and the indicators to help monitor the quality of cancer screening.
Each small group session will share discussion points with plenary.
13:45 – 14:45
15:00 – 15:30
Breast cancer screening break-out session
Moderator: Greg Doyle
Chair, Canadian Breast Cancer Screening
Initiative
Cervical cancer screening break-out session
Moderator: Meg McLachlin
Chair, Pan-Canadian Cervical Cancer
Screening Initiative
Colorectal cancer screening break-out session
Moderator: Heather Bryant
Chair, National Colorectal Cancer Screening
Network
Recap break-out discussions with plenary
All break-out session moderators
Moderator: Verna Mai
Canadian Partnership Against Cancer
BREAK (15:30 – 15:45 pm)
15:45 – 16:15
16:15 – 16:30
Cancer Risk Management
A tool to assist in the planning of cancer
screening strategies, projecting potential
burden of disease, economic impact and costeffectiveness of different cancer control
interventions
Janey Shin
Director, Surveillance and Analytics, Canadian
Partnership Against Cancer
Closing Remarks and Day 1 adjournment
Verna Mai
Canadian Partnership Against Cancer
Fei-Fei Liu
Program Manager, Cancer Risk Management
Modelling, Canadian Partnership Against
Cancer
4
Canadian Cancer Screening Conference: Maximizing Benefits, Minimizing Harms
DRAFT Agenda
Montreal, Quebec
March 21-22, 2012
DAY 2
A hot breakfast will be served (7:30-8:30 am)
8:30-8:40
Welcome and opening remarks
Verna Mai
Canadian Partnership Against Cancer
LATEST EVIDENCE ON CANCER SCREENING TESTS
A series of presentations sharing current evidence on new screening tests and the key issues for them over the
next five years.
8:40 – 8:55
Canadian Partnership Against Cancer’s
Anticipatory Science initiative – An Overview
Verna Mai
Canadian Partnership Against Cancer
8:55 – 9:15
Lung cancer screening
Christine Berg
Chief, Early Detection Research Group,
Division of Cancer Prevention, National
Cancer Institute, U.S.A.
9:15 – 9:30
Ovarian cancer screening
Anthony Miller
Professor Emeritus, Dalla Lana School of
Public Health, University of Toronto, Canada
(Ontario)
9:30 – 9:45
Prostate cancer screening – The randomized
PSA screening trials: Interpreting the
difference
Tom Pickles
Radiation Oncology, BC Cancer Agency
Professor, Department of Surgery,
University of British Columbia, Canada
(British Columbia)
9:45 – 10:00
Panel Q&A for all three presentations
All presenters
Moderator: Verna Mai
Canadian Partnership Against Cancer
MORNING BREAK (10:00-10:30 am)
5
PANEL PRESENTATION
A series of presentations that will look at how new screening tests can be implemented – considering the need for
comprehensive cancer screening programs or whether quality indicators will be sufficient to monitor quality in
health services. International perspectives will be shared.
10:30 – 11:10
The Future of Screening – How will new
screening programs and testing services be
delivered, maximizing benefits and minimizing
harms?
Christine Berg
National Cancer Institute, U.S.A.
Julietta Patnick,
National Health Services, U.K.
Stephen Taplin
National Cancer Institute, U.S.A.
Graeme Young
Flinders University, Australia
11:10 – 11:35
Panel Q&A for all presentations
All presenters
Moderator: Verna Mai
Canadian Partnership Against Cancer
11:35 – 11:55
Success in early detection – Goals and
signposts
A look at the key requirements to ensure that
benefits are maximized and potential harms are
minimized with cancer screening
Heather Bryant
Chair, National Colorectal Cancer Screening
Network
Canadian Partnership Against Cancer
11:55 – 12:10
Closing remarks and conference adjournment
Verna Mai
Canadian Partnership Against Cancer
LUNCH (12:15 – 13:30)
Thank you for participating in the Canadian Cancer Screening Conference 2012
6